Abstract: The present invention relates to the diagnosis and treatment of B-cell disorders such as multiple myeloma (MM). In particular, the present invention relates to the treatment of B-cell disorders using ligands which bind to free lambda light chains expressed on the surface of lymphoid cancer cells.
Type:
Application
Filed:
February 28, 2005
Publication date:
May 1, 2008
Applicant:
PACMAB LIMITED
Inventors:
Rosanne D. Dunn, Darren R. Jones, Parisa Asvadi, Robert L. Raison, Andrew T. Hutchinson